With the injectable antiretroviral drug lenacapavir found to be “safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a...
The findings point to a need for parent-focused messaging through media, the internet and medical providers to answer questions and alleviate concerns parents have...
Low uptake of daily oral PrEP since US Food and Drug Administration approval and low medication adherence among users have stimulated the investigation of...